Lipoplatin monotherapy: A phase II trial of second-line treatment of metastatic non-small-cell lung cancer. (Record no. 18735609)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01514 a2200457 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515163157.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200906s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1973-9478 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1179/joc.2009.21.1.86 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ravaioli, A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20090605 |
245 00 - TITLE STATEMENT | |
Title | Lipoplatin monotherapy: A phase II trial of second-line treatment of metastatic non-small-cell lung cancer. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of chemotherapy (Florence, Italy) |
Date of publication, distribution, etc. | Feb 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 86-90 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cisplatin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lung Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Papi, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pasquini, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marangolo, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rudnas, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fantini, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nicoletti, S V L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Drudi, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Panzini, I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tamburini, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gianni, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pasini, G |
773 0# - HOST ITEM ENTRY | |
Title | Journal of chemotherapy (Florence, Italy) |
Related parts | vol. 21 |
-- | no. 1 |
-- | p. 86-90 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1179/joc.2009.21.1.86">https://doi.org/10.1179/joc.2009.21.1.86</a> |
Public note | Available from publisher's website |
No items available.